Page last updated: 2024-08-22

trimetazidine and malonyl coenzyme a

trimetazidine has been researched along with malonyl coenzyme a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kantor, PF; Kozak, R; Lopaschuk, GD; Lucien, A	1

Other Studies

1 other study(ies) available for trimetazidine and malonyl coenzyme a

Article	Year
The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circulation research, 2000, Mar-17, Volume: 86, Issue:5 Topics: Angina Pectoris; Animals; Carboxy-Lyases; Dose-Response Relationship, Drug; Energy Metabolism; Esters; Fatty Acids; Glucose; Glycolysis; Male; Malonyl Coenzyme A; Mitochondria; Mitochondrial Trifunctional Protein; Multienzyme Complexes; Myocardial Ischemia; Myocardium; Pyruvate Dehydrogenase Complex; Rats; Rats, Sprague-Dawley; Trimetazidine; Vasodilator Agents	2000

Article

Year

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.

Circulation research, 2000, Mar-17, Volume: 86, Issue:5

Topics: Angina Pectoris; Animals; Carboxy-Lyases; Dose-Response Relationship, Drug; Energy Metabolism; Esters; Fatty Acids; Glucose; Glycolysis; Male; Malonyl Coenzyme A; Mitochondria; Mitochondrial Trifunctional Protein; Multienzyme Complexes; Myocardial Ischemia; Myocardium; Pyruvate Dehydrogenase Complex; Rats; Rats, Sprague-Dawley; Trimetazidine; Vasodilator Agents

2000